servier.us Open in urlscan Pro
2001:41d0:301::26  Public Scan

Form analysis
2 forms found in the DOM

GET https://servier.us/

<form role="search" method="get" class="search-form" action="https://servier.us/">
  <label>
    <span class="sr-only"> Search for: </span>
    <input type="search" placeholder="Search …" value="" name="s" autocomplete="off">
  </label>
  <button type="submit" title="Search"><svg aria-label="Search" class="search" aria-hidden="true" width="13" height="13" viewBox="0 0 13 13" xmlns="http://www.w3.org/2000/svg">
      <g transform="translate(1)" stroke="#24226A" stroke-width="1.08" fill="none" fill-rule="evenodd">
        <ellipse cx="7.419" cy="4.525" rx="4.041" ry="3.985"></ellipse>
        <path stroke-linecap="round" stroke-linejoin="round" d="M4.451 7.481 0 12"></path>
      </g>
    </svg></button>
</form>

POST https://servier.us/wp-admin/admin-ajax.php

<form method="post" action="https://servier.us/wp-admin/admin-ajax.php">
  <p class="mb-6 text-indigo-900 text-sm">Subscribe to email alerts to be informed each time a new article is published on the servier.com website.</p>
  <div class="mb-6">
    <label class="inline-block align-middle mb-0 mr-2" for="operation">I wish to…</label>
    <div class="button-group inline-block align-middle">
      <button type="button" data-value="subscribe" class="selected">Subscribe</button>
      <button type="button" data-value="unsubscribe">Unsubscribe</button>
      <input type="hidden" name="operation" value="subscribe">
    </div>
  </div>
  <label for="email">Your email address</label>
  <input type="email" name="email" class="mb-6 form-input" id="email" aria-required="true" placeholder="test@example.com">
  <p class="text-indigo-900 text-xs mb-6">By subscribing to email alerts, you agree to Servier's use of your personal data as described in the <a href="https://servier.us/">data protection policy</a>.</p>
  <button type="submit" class="wpcf7-submit wp-block-button__link anim-active">Send</button>
  <div class="response"></div>
  <input type="hidden" name="nonce" value="8f145948c1">
</form>

Text Content

Skip to content
Search for:
 * Contact Servier
 * Submit Search

 * About Servier in the U.S.
   * Executive Leadership
   * Press Releases
   * Awards & Recognition
 * Patient Services
   * Expanded Access
   * Acute Lymphoblastic Leukemia
   * Acute Myeloid Leukemia
   * Cholangiocarcinoma
   * Myelodysplastic Syndromes
   * Mutant IDH Inhibition
 * Research & Development
   * Clinical Trials
   * Servier’s Pipeline
 * Medicines
 * Corporate Responsibility
   * Where We Stand on Key Issues
   * Value and Access Principles
   * Commitment to Sustainability
   * Manufacturing and Supply Chain
   * Grants and Funding
   * Ethics & Compliance
 * Newsroom
   * News
 * Join our team

Discover Servier


WELCOME TO SERVIER U.S.



Visit
Servier Global

SERVIER'S COMMITMENT


IMPROVING THE LIVES OF OUR PATIENTS

We work tirelessly to deliver meaningful therapeutics for the patients we serve.

Learn more

OUR REPUTATION


ABOUT SERVIER

Servier is a leader in oncology, dedicated to addressing rare and patient
populations with unmet needs. Our unwavering commitment is centered on
delivering the promise of a brighter tomorrow to the patients we serve.

Learn more

OUR SCIENCE


RESEARCH & DEVELOPMENT

We are moved by science. To address the unmet need of patients, our practice
changing R&D pipeline and in-house capabilities are complimented by a robust
partnership network.

Learn More

SERVIER'S ACCOUNTABILITY


RESPONSIBILITY

Our responsibility is to help make the world a better place for our patients and
their families. We are committed to creating a brighter future for all of us.



Learn More

SPONSORSHIP


GRANTS & FUNDING

We are proud to be able to offer financial assistance to not only support
patients and their families, but a variety of U.S.-focused advocacy groups and
healthcare professionals, as well.

 

Learn More

ACCOLADES


AWARDS & RECOGNITION

When exceptional science aligns with exceptional individuals, the potential
becomes boundless – and the recognition is undeniable.

Learn More







ONCOLOGY






SMALLER PATIENT POPULATIONS ARE NOT DETERRENTS FOR SERVIER; RATHER, THEY ARE THE
CANVASES UPON WHICH OUR SCIENTISTS PAINT INNOVATIVE AND IMPACTFUL SOLUTIONS.

R&D Pipeline
37 Active Servier Oncology Programs
21 Pre-Clinical
8 Phase 1
2 Phase 2
3 Phase 3
3 Filing


CAREER


SEE A FUTURE AT SERVIER?




WORKING AT SERVIER PHARMACEUTICALS

Our company also boasts and inclusive culture where great people and great
science make a difference in the lives of the patients we serve.

Join our team




NEWSROOM


LATEST SERVIER NEWS


Press Release

06.14.2024

Boston Business Journal Names Servier Pharmaceuticals a Best Places to Work for
the Fourth Consecutive Year

Boston Business Journal Names Servier Pharmaceuticals a Best Places to Work for
the Fourth Consecutive Year
Press Release

05.30.2024

Servier Initiates Critical Dialogue on AYA Cancer Survivorship at ASCO 2024

Servier Initiates Critical Dialogue on AYA Cancer Survivorship at ASCO 2024
Press Release

05.23.2024

Servier Highlights Commitment to Improving Cancer Outcomes at ASCO 2024

Servier Highlights Commitment to Improving Cancer Outcomes at ASCO 2024

More News

logo_twitter logo_linkedin logo_youtube
 * Privacy policy
 * Community Guidelines
 * Report a side effect
 * Sitemap
 * “The use of ‘Servier US’ refers to the activities of Servier Pharmaceuticals
   LLC and Servier Bio-Innovation.”

©2024 LES LABORATOIRES SERVIER


SUBSCRIBE TO EMAIL ALERTS

Subscribe to email alerts to be informed each time a new article is published on
the servier.com website.

I wish to…
Subscribe Unsubscribe
Your email address

By subscribing to email alerts, you agree to Servier's use of your personal data
as described in the data protection policy.

Send